Vontobel Holding Ltd. Novo Cure LTD Transaction History

Vontobel Holding Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	BUY	$40.29 - $82.51 $37,832 - $77,476	939 Added 21.32%	5,343 $221,000
Q2 2023 Jul 24, 2023	BUY	$40.29 - $82.51 $51,490 - $105,447	1,278 Added 20.23%	7,596 $315,000
Q1 2023 Jun 03, 2024	BUY	$56.44 - $118.81 $248,561 - $523,239	4,404 New	4,404 $264,000
Q1 2023 Apr 12, 2023	BUY	$56.44 - $118.81 $57,230 - $120,473	1,014 Added 19.12%	6,318 $379,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $161,485 - $215,473	2,524 Added 90.79%	5,304 $389,000
Q3 2022 Nov 04, 2022	BUY	$67.99 - $89.57 $189,012 - $249,004	2,780 New	2,780 $210,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $264,118 - $371,127	-4,391 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $89,570 - $145,534	-1,193 Reduced 21.36%	4,391 $350,000
Q3 2021 Oct 29, 2021	BUY	$116.17 - $194.55 $151,253 - $253,304	1,302 Added 30.41%	5,584 $649,000
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $558,372 - $965,933	4,282 New	4,282 $959,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.